Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

HER2

Items 1-10 of 14

Page
per page
  1. Tyrphostin AG 879
    B1544 Tyrphostin AG 879
    Summary: HER2 inhibitor
  2. Mubritinib (TAK 165)
    B1543 Mubritinib (TAK 165)
    Target: ErbB
    Summary: Potent inhibitor of HER2/ErbB2
      insoluble in H2O; ≥76.9 mg/mL
  3. TAK-285
    A8528 TAK-285
    Target: EGFR|HER2
    Summary: HER2/EGFR(HER1) inhibitor
      ≥27.4 mg/mL
  4. Neratinib (HKI-272)
    A8322 Neratinib (HKI-272)
     3 Citation
    Target: EGFR
    Summary: HER2/EGFR inhibitor,potent and irreversible
      insoluble in H2O; ≥13.93 mg/mL
  5. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  6. Lapatinib
    A8218 Lapatinib
     7 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  7. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: Multitargeted HDAC inhibitor
      ≥21.7 mg/mL
  8. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  9. Canertinib dihydrochloride
    A3276 Canertinib dihydrochloride
    Summary: Pan-ErbB inhibitor, potent and selective
      ≥21.8 mg/mL
  10. BMS-599626 Hydrochloride
    A3252 BMS-599626 Hydrochloride
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥29.05 mg/mL

Items 1-10 of 14

Page
per page